- Clinical Trials
- August 2024
- 80 Pages
Global
From €1917EUR$2,000USD£1,602GBP
- Report
- April 2024
- 89 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- April 2024
- 81 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- April 2024
- 75 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Dapsone is a sulfone antibiotic used to treat acne. It is a topical medication that is applied directly to the skin. It works by reducing inflammation and killing bacteria that cause acne. It is often used in combination with other acne medications, such as benzoyl peroxide or topical retinoids. Dapsone is generally well tolerated and has few side effects. It is available in both generic and brand-name formulations.
The market for dapsone is growing as more people seek treatment for acne. It is a popular choice for those who want an effective treatment without the potential side effects of other acne medications. It is also a cost-effective option, as generic formulations are available.
Companies in the dapsone market include GlaxoSmithKline, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more